224 related articles for article (PubMed ID: 29330286)
1. Agonist-induced CXCR4 and CB2 Heterodimerization Inhibits Gα13/RhoA-mediated Migration.
Scarlett KA; White EZ; Coke CJ; Carter JR; Bryant LK; Hinton CV
Mol Cancer Res; 2018 Apr; 16(4):728-739. PubMed ID: 29330286
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression.
Coke CJ; Scarlett KA; Chetram MA; Jones KJ; Sandifer BJ; Davis AS; Marcus AI; Hinton CV
J Biol Chem; 2016 May; 291(19):9991-10005. PubMed ID: 26841863
[TBL] [Abstract][Full Text] [Related]
3. A Blk-p190RhoGAP signaling module downstream of activated Gα13 functionally opposes CXCL12-stimulated RhoA activation and cell invasion.
Bartolomé RA; Díaz-Martínez M; Coló GP; Arellano-Sánchez N; Torres-Ayuso P; Kleinovink JW; Mérida I; Teixidó J
Cell Signal; 2014 Nov; 26(11):2551-61. PubMed ID: 25025568
[TBL] [Abstract][Full Text] [Related]
4. The interaction of Gα13 with integrin β1 mediates cell migration by dynamic regulation of RhoA.
Shen B; Estevez B; Xu Z; Kreutz B; Karginov A; Bai Y; Qian F; Norifumi U; Mosher D; Du X
Mol Biol Cell; 2015 Oct; 26(20):3658-70. PubMed ID: 26310447
[TBL] [Abstract][Full Text] [Related]
5. The GNA13-RhoA signaling axis suppresses expression of tumor protective Kallikreins.
Teo CR; Casey PJ; Rasheed SA
Cell Signal; 2016 Oct; 28(10):1479-88. PubMed ID: 27424208
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion.
Nasser MW; Qamri Z; Deol YS; Smith D; Shilo K; Zou X; Ganju RK
PLoS One; 2011; 6(9):e23901. PubMed ID: 21915267
[TBL] [Abstract][Full Text] [Related]
7. Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cells.
O'Hayre M; Inoue A; Kufareva I; Wang Z; Mikelis CM; Drummond RA; Avino S; Finkel K; Kalim KW; DiPasquale G; Guo F; Aoki J; Zheng Y; Lionakis MS; Molinolo AA; Gutkind JS
Oncogene; 2016 Jul; 35(29):3771-80. PubMed ID: 26616858
[TBL] [Abstract][Full Text] [Related]
8. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
Panneerselvam J; Jin J; Shanker M; Lauderdale J; Bates J; Wang Q; Zhao YD; Archibald SJ; Hubin TJ; Ramesh R
PLoS One; 2015; 10(3):e0122439. PubMed ID: 25775124
[TBL] [Abstract][Full Text] [Related]
9. AGTR1 promotes lymph node metastasis in breast cancer by upregulating CXCR4/SDF-1α and inducing cell migration and invasion.
Ma Y; Xia Z; Ye C; Lu C; Zhou S; Pan J; Liu C; Zhang J; Liu T; Hu T; Xie L; Wu G; Zhao Y
Aging (Albany NY); 2019 Jun; 11(12):3969-3992. PubMed ID: 31219799
[TBL] [Abstract][Full Text] [Related]
10. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
Zhu WB; Zhao ZF; Zhou X
J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000
[TBL] [Abstract][Full Text] [Related]
11. The Galpha13-Rho signaling axis is required for SDF-1-induced migration through CXCR4.
Tan W; Martin D; Gutkind JS
J Biol Chem; 2006 Dec; 281(51):39542-9. PubMed ID: 17056591
[TBL] [Abstract][Full Text] [Related]
12. A synthetic biology approach reveals a CXCR4-G13-Rho signaling axis driving transendothelial migration of metastatic breast cancer cells.
Yagi H; Tan W; Dillenburg-Pilla P; Armando S; Amornphimoltham P; Simaan M; Weigert R; Molinolo AA; Bouvier M; Gutkind JS
Sci Signal; 2011 Sep; 4(191):ra60. PubMed ID: 21934106
[TBL] [Abstract][Full Text] [Related]
13. Gα13/PDZ-RhoGEF/RhoA signaling is essential for gastrin-releasing peptide receptor-mediated colon cancer cell migration.
Patel M; Kawano T; Suzuki N; Hamakubo T; Karginov AV; Kozasa T
Mol Pharmacol; 2014 Sep; 86(3):252-62. PubMed ID: 24958816
[TBL] [Abstract][Full Text] [Related]
14. Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer.
Mao TL; Fan KF; Liu CL
Gene Ther; 2017 Oct; 24(10):621-629. PubMed ID: 28753202
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator‑activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis.
Qin L; Gong C; Chen AM; Guo FJ; Xu F; Ren Y; Liao H
Mol Med Rep; 2014 Aug; 10(2):695-700. PubMed ID: 24842333
[TBL] [Abstract][Full Text] [Related]
16. Gα12/13 signaling promotes cervical cancer invasion through the RhoA/ROCK-JNK signaling axis.
Yuan B; Cui J; Wang W; Deng K
Biochem Biophys Res Commun; 2016 May; 473(4):1240-1246. PubMed ID: 27084452
[TBL] [Abstract][Full Text] [Related]
17. Gastrin stimulates pancreatic cancer cell directional migration by activating the Gα12/13-RhoA-ROCK signaling pathway.
Mu G; Ding Q; Li H; Zhang L; Zhang L; He K; Wu L; Deng Y; Yang D; Wu L; Xu M; Zhou J; Yu H
Exp Mol Med; 2018 May; 50(5):1-14. PubMed ID: 29717112
[TBL] [Abstract][Full Text] [Related]
18. PDZ-RhoGEF is essential for CXCR4-driven breast tumor cell motility through spatial regulation of RhoA.
Struckhoff AP; Rana MK; Kher SS; Burow ME; Hagan JL; Del Valle L; Worthylake RA
J Cell Sci; 2013 Oct; 126(Pt 19):4514-26. PubMed ID: 23868972
[TBL] [Abstract][Full Text] [Related]
19. Gα13 and Rho mediate endosomal trafficking of CXCR4 into Rab11+ vesicles upon stromal cell-derived factor-1 stimulation.
Kumar A; Kremer KN; Dominguez D; Tadi M; Hedin KE
J Immunol; 2011 Jan; 186(2):951-8. PubMed ID: 21148034
[TBL] [Abstract][Full Text] [Related]
20. Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 signaling and promotes medulloblastoma migration.
Yuan L; Zhang H; Liu J; Rubin JB; Cho YJ; Shu HK; Schniederjan M; MacDonald TJ
Mol Cancer; 2013 Mar; 12():18. PubMed ID: 23497290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
